CLINICAL_TRIALS
trial_result
· 2020-08-19
Clinical Trial Update: Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy [Phase 4]
Summary
Phase 4 open-label safety and efficacy study of levetiracetam in epilepsy (partial seizures) completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Epilepsy, Partial | Phase 4 | Status: COMPLETED | Results posted: 2020-08-19